- Home
- CDXS vs IHRT Comparison
CDXS vs IHRT Comparison
Compare CDXS & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- IHRT
- Stock Information
- Founded
- CDXS 2002
- IHRT 1974
- Country
- CDXS United States
- IHRT United States
- Employees
- CDXS N/A
- IHRT N/A
- Industry
- CDXS Major Chemicals
- IHRT Broadcasting
- Sector
- CDXS Industrials
- IHRT Consumer Discretionary
- Exchange
- CDXS Nasdaq
- IHRT Nasdaq
- Market Cap
- CDXS 201.3M
- IHRT 193.4M
- IPO Year
- CDXS 2010
- IHRT 2019
- Fundamental
- Price
- CDXS $3.04
- IHRT $2.03
- Analyst Decision
- CDXS Buy
- IHRT Buy
- Analyst Count
- CDXS 2
- IHRT 3
- Target Price
- CDXS $11.00
- IHRT $2.92
- AVG Volume (30 Days)
- CDXS 910.6K
- IHRT 780.4K
- Earning Date
- CDXS 08-07-2025
- IHRT 08-07-2025
- Dividend Yield
- CDXS N/A
- IHRT N/A
- EPS Growth
- CDXS N/A
- IHRT N/A
- EPS
- CDXS N/A
- IHRT N/A
- Revenue
- CDXS $49,815,000.00
- IHRT $3,862,595,000.00
- Revenue This Year
- CDXS $12.77
- IHRT N/A
- Revenue Next Year
- CDXS $22.12
- IHRT $5.89
- P/E Ratio
- CDXS N/A
- IHRT N/A
- Revenue Growth
- CDXS N/A
- IHRT 3.31
- 52 Week Low
- CDXS $1.90
- IHRT $0.95
- 52 Week High
- CDXS $6.08
- IHRT $2.84
- Technical
- Relative Strength Index (RSI)
- CDXS 69.54
- IHRT 73.86
- Support Level
- CDXS $2.55
- IHRT $1.64
- Resistance Level
- CDXS $2.91
- IHRT $2.13
- Average True Range (ATR)
- CDXS 0.20
- IHRT 0.13
- MACD
- CDXS 0.06
- IHRT 0.02
- Stochastic Oscillator
- CDXS 96.17
- IHRT 87.76
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.